Interleukin-12 immunohistochemistry as a diagnostic tool for patch-stage mycosis fungoides - 15/10/16
Doi : 10.1016/j.jaad.2016.06.019
David M. Lemchak, DO a, Oleg E. Akilov, MD, PhD b, ⁎ 
a Lake Erie College of Osteopathic Medicine, Erie
b Department of Dermatology, University of Pittsburgh, Pennsylvania
∗Reprint requests: Oleg E. Akilov, MD, PhD, Department of Dermatology, University of Pittsburgh, 3708 Fifth Avenue, 5th Floor, Suite 500.68, Pittsburgh, PA 15213Department of DermatologyUniversity of Pittsburgh3708 Fifth Avenue, 5th Floor, Suite 500.68PittsburghPA15213
| The study was approved by the institutional review board of the University of Pittsburgh Medical Center (IRB#0411029) and registered in clinicaltrials.gov (NCT00177268) as a tissue and blood banking protocol for CTCL patients for current and future CTCL research. |
|
| Funding source: None. |
|
| Conflicts of interest: None declared. |
© 2016
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 75 - N° 5
P. 1053-1054 - novembre 2016 Retour au numéro
Article précédent
- Eruptive nevi associated with medications (ENAMs)
- Benjamin M. Perry, Anne Nguyen, Bryce L. Desmond, Collin M. Blattner, R. Scott Thomas, R. John Young
- Evaluating the skin in patients undergoing chimeric antigen receptor modified T-cell therapy
- Courtney B. Rubin, Rosalie Elenitsas, Laura Taylor, Simon F. Lacey, Irina Kulikovskaya, Minnal Gupta, Jan J. Melenhorst, Alison Loren, Noelle Frey, Carl H. June, David Porter, Misha Rosenbach
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?